US Stock MarketDetailed Quotes

AORT Artivion

Watchlist
  • 29.000
  • -0.340-1.16%
Close Dec 27 16:00 ET
  • 29.000
  • 0.0000.00%
Post 16:01 ET
1.22BMarket Cap-966.67P/E (TTM)

About Artivion Company

Artivion, Inc. engages in the research and development of solutions which address cardiac and vascular surgeons' clinical challenges in treating patients with aortic diseases. Its products include aortic stents and stent grafts, prosthetic heart valves, cryopreserved cardiac and vascular allografts, and surgical sealants. It operates through the Medical Devices and Preservation Services segments. The Medical Devices segment includes aortic stents and stent grafts, surgical sealants, and On-X products. The Preservation Services segment offers cardiac and vascular tissue preservation services. The company was founded on January 19, 1984, and is headquartered in Kennesaw, GA.

Company Profile

SymbolAORT
Company NameArtivion
Listing DateJul 15, 1997
Issue Price10.00
Founded1984
CEOMr. James Patrick Mackin
MarketNYSE
Employees1500
Fiscal Year Ends12-31
Address1655 Roberts Boulevard NW
CityKennesaw
ProvinceGeorgia
CountryUnited States of America
Zip Code30144-3632
Phone1-770-419-3355

Company Executives

  • Name
  • Position
  • Salary
  • James Patrick Mackin
  • Chairman of the Board, President and Chief Executive Officer
  • 3.18M
  • Dr. Marshall S. Stanton, M.D.
  • Senior Vice President, Clinical Research and Chief Medical Officer
  • --
  • Lance A. Berry, C.P.A.
  • Chief Financial Officer and Executive Vice President, Finance
  • 1.64M
  • Amy D. Horton, C.P.A.
  • Vice President and Chief Accounting Officer
  • 1.06M
  • Jean F. Holloway, Esq.
  • Senior Vice President, General Counsel, Chief Compliance Officer and Secretary
  • 993.72K
  • Matthew A. Getz
  • Vice President, Human Resources
  • --
  • John E. Davis
  • Senior Vice President, Global Sales and Marketing
  • 953.41K
  • Florian Tyrs
  • Vice President, Global Operations
  • --
  • Dr. Robert C. Thon, PhD
  • Vice President, Research and Development
  • --
  • Rochelle L. Maney
  • Vice President, Global Quality
  • --
  • Andrew M. Green
  • Vice President, Regulatory Affairs
  • --
  • Thomas F. Ackerman
  • Independent Director
  • 230.00K
  • Marna P. Borgstrom
  • Independent Director
  • 220.00K
  • Jeffrey H. Burbank
  • Lead Independent Director
  • 265.00K
  • James W. Bullock
  • Independent Director
  • 217.50K
  • Daniel J. Bevevino
  • Independent Director
  • 235.00K
  • Anthony B. Semedo
  • Independent Director
  • 217.50K
  • Elizabeth A. Hoff
  • Independent Director
  • 210.00K
  • Jon W. Salveson
  • Independent Director
  • 215.00K
Heat List
US
Overall
Symbol
Price
% Chg

No Data